GSK1324726A
GSK1324726A (I-BET726) is a potent and selective BET bromodomain inhibitor, exhibiting IC50 values of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively. This tool compound is widely used in vitro and in vivo to investigate BET protein function in oncology, immunology, and inflammatory disease research.
Product Specifications
CAS Number
1300031-52-0
Product Name Alternative
BRD2, BRD3, BRD4, Apoptosis, inhibit, Inhibitor, I-BET 726, I-BET726, I-BET-726, GSK1324726A, GSK-1324726A, Epigenetic Reader Domain, EpigeneticReaderDomain
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
98.34% (May vary between batches)
Solubility
DMSO:50 mg/mL (114.97 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.6 mM) ; Ethanol:80 mg/mL (183.95 mM)
Smiles
C (C) (=O) N1C=2C ([C@H] (NC3=CC=C (Cl) C=C3) C[C@@H]1C) =CC (=CC2) C4=CC=C (C (O) =O) C=C4
Molecular Formula
C25H23ClN2O3
Molecular Weight
434.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SDC98613-01 50 mg
2-Chloro-5-[ (4-fluorophenyl) methyl]-1,3,4-thiadiazole
Sign In for Pricing
View Details